BJL
EDIT icon

Brighton Jones LLC’s Editas Medicine EDIT Stock Holding History

Brighton Jones LLC’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.5K Buy
+17,751
New +$51.9K ﹤0.01% 1360

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Brighton Jones LLC's EDIT Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in Editas Medicine (EDIT) in Q2 2026: 17,751 shares worth $57.5K. The stake represents ﹤0.01% of the portfolio and ranks #1360 among its holdings.

102 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Brighton Jones LLC held 17,751 shares of Editas Medicine worth $57.5K as of Q2 2026.
  • Editas Medicine was a new Brighton Jones LLC position in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1360 holding.
  • 102 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.